Synonym(s):
|
Detection of IgM Antibodies to Zika Virus
by Immunochromatographic Assay (ICA), Chembio Dual Path Platform (DPP) Assay System. Rapid point-of-care diagnostic test. |
Requisition
Form
|
G-2V
|
Test
Description
|
Qualitative Immunochromatographic Assay (ICA) for the presumptive detection of IgM antibodies to Zika
virus using Chembio DPP Assay system..
|
Pre-Approval
Needed
|
N/A
|
Supplemental
Information Required
|
N/A
|
Supplemental
Form(s)
|
N/A
|
Performed on
Specimens from (sources)
|
Human
|
Sample/Specimen
Type for Testing
|
Serum
|
Minimum
Volume/Size Required
|
1.0 mL
|
Storage/Preservation
Prior to Shipping
|
Serum separated from the clot may be
stored at 2°C to 8°C up to 48 hours, but then must be frozen at -20°C or
colder until shipped.
|
Transport
Medium
|
N/A
|
Specimen
Labeling
|
At least 2 patient specific identifiers: First
and last name as one identifier and a DOB or a unique patient specific
identifier (e.g. Medical Record number); must match information on submission form (G-2A).
|
Shipping and
Specimen Handling Requirements
|
- Ship according to Dangerous Goods Regulations,
IATA, and/or CFR 49.
- Handle
as infectious agent using universal precautions.
- Triple
contain in accordance with federal shipping regulations for infectious
agents.
Additional forms & resources
|
Method
|
ICA, lateral flow test, rapid test
|
Turn-around
Time
|
7 working days
|
Interferences/Limitations
|
Most common cause of false positive
results is cross-reactivity with IgM specific for other flaviviruses.
|
Common Causes for
Rejection
|
Insufficient
quantity, unacceptable specimen type or source, improper shipping conditions,
expired media or collection container, discrepancies between specimen label
and submission form, and/or incomplete or missing submission form.
|
Additional Information
|
Minimum volume for CDC confirmation
testing 0.5 mL.
|